Author: Jishnu Nair

A joint venture between two companies is creating a mushroom factory in Houston. Its first customers will be the city’s Asian population.

EndoQuest’s flexible endoscopy robot system is set to begin human trials next year at sites across the country, including in Houston.

A company building data center components will receive a tax break from Houston for jobs at a 1.2 million-square-foot warehouse.

The Texas Medical Center’s venture fund is still spending its initial investment, but its CEO said external investors will be tapped for future fundraising.

The Texas Medical Center is looking for new locations for a cell therapy manufacturing site after announcing a 500-acre BioPort campus plan in 2022.

Houston AI company OmniScience hit a major milestone with a new partnership, and its CEO said it will be the first of many models in clinical trials.

Houston-based unicorn Cart.com’s latest deal also gave it more real estate across the country as the company continues to look for a Houston office.

Houston-based Bivacor, which first implanted its revolutionary artificial heart in 2024, is set to expand its trial in the U.S. early next year.

As NASA announced its decision to postpone its upcoming Artemis missions, experts and company leaders identified ripple effects in Houston.

The new Texas Space Commission has nearly $3 billion in applications to process, so it canceled its December meeting.